Jun Fei Feng
Financieel Directeur/CFO bij Beijing Shenogen Pharma Group Ltd.
Profiel
Jun Fei Feng is currently the CFO, Board Secretary & Deputy GM at Beijing Shenogen Pharma Group Ltd.
He previously worked as a Secretary at Beijing Hanbang Technology Corp.
Mr. Feng graduated from Central University of Finance & Economics with a graduate degree in 2008 and from Northwest University of Politics & Law with an undergraduate degree in 2005.
Actieve functies van Jun Fei Feng
Bedrijven | Functie | Begin |
---|---|---|
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Financieel Directeur/CFO | 01-09-2019 |
Eerdere bekende functies van Jun Fei Feng
Bedrijven | Functie | Einde |
---|---|---|
BEIJING HANBANG TECHNOLOGY CORP. | Bedrijfssecretaris | - |
Opleiding van Jun Fei Feng
Northwest University of Politics & Law | Undergraduate Degree |
Central University of Finance & Economics | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
BEIJING HANBANG TECHNOLOGY CORP. | Electronic Technology |
Bedrijven in privébezit | 1 |
---|---|
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Health Technology |